Artificial intelligence and pediatric acute kidney injury: a mini-review and white paper

Area of Science:

• Pediatric Nephrology
• Artificial Intelligence in Medicine
• Computational Biology

Background:

• Pediatric and neonatal acute kidney injury (AKI) presents diagnostic and management challenges, often leading to delayed detection and long-term complications like hypertension and chronic kidney disease.
• Early identification and intervention are crucial for mitigating the severe consequences of AKI in young populations.

Purpose of the Study:

• To explore the application of artificial intelligence (AI) models for the early detection, risk stratification, and personalized management of pediatric AKI.
• To investigate how AI can improve clinical decision-making and identify distinct AKI subphenotypes for tailored interventions.
• To assess the potential of integrating AI with existing clinical tools to enhance predictive accuracy in pediatric nephrology.

Main Methods:

• Application of supervised and unsupervised machine learning models for AKI prediction in pediatric populations.
• Exploration of AI integration with established risk scores and biomarkers to improve diagnostic and prognostic capabilities.
• Analysis of AI's role in identifying patient subphenotypes with differential responses to treatment.

Main Results:

• AI models demonstrate potential for early AKI detection and risk stratification in pediatric patients.
• Integration of AI with existing clinical data enhances predictive accuracy for AKI.
• AI facilitates the identification of novel AKI subphenotypes, paving the way for personalized treatment strategies.

Conclusions:

• AI holds significant promise for revolutionizing pediatric nephrology by enabling earlier and more accurate AKI diagnosis and management.
• Addressing challenges such as data quality, algorithmic bias, and ethical implementation is essential for successful AI adoption.
• Future research should focus on incorporating diverse biomarkers, external validation, and ensuring equitable access to AI-driven tools for optimal pediatric AKI care.